Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Marital Status and Cardiovascular Health: Is There a Link?

Schaer GL, Braun L.

Cardiovasc Revasc Med. 2018 Apr - May;19(3 Pt B):A3-A4. doi: 10.1016/j.carrev.2018.05.016. No abstract available.

PMID:
29934002
2.

Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.

Henry TD, Losordo DW, Traverse JH, Schatz RA, Jolicoeur EM, Schaer GL, Clare R, Chiswell K, White CJ, Fortuin FD, Kereiakes DJ, Zeiher AM, Sherman W, Hunt AS, Povsic TJ.

Eur Heart J. 2018 Jun 14;39(23):2208-2216. doi: 10.1093/eurheartj/ehx764.

PMID:
29315376
3.

Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA® catheter mapping.

Sharma GK, Poulin MF, Schaer GL.

Cardiovasc Revasc Med. 2017 May 13. pii: S1553-8389(17)30174-4. doi: 10.1016/j.carrev.2017.05.011. [Epub ahead of print]

PMID:
28539211
4.

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

Quyyumi AA, Vasquez A, Kereiakes DJ, Klapholz M, Schaer GL, Abdel-Latif A, Frohwein S, Henry TD, Schatz RA, Dib N, Toma C, Davidson CJ, Barsness GW, Shavelle DM, Cohen M, Poole J, Moss T, Hyde P, Kanakaraj AM, Druker V, Chung A, Junge C, Preti RA, Smith RL, Mazzo DJ, Pecora A, Losordo DW.

Circ Res. 2017 Jan 20;120(2):324-331. doi: 10.1161/CIRCRESAHA.115.308165. Epub 2016 Nov 7.

5.

The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.

Povsic TJ, Henry TD, Traverse JH, Fortuin FD, Schaer GL, Kereiakes DJ, Schatz RA, Zeiher AM, White CJ, Stewart DJ, Jolicoeur EM, Bass T, Henderson DA, Dignacco P, Gu Z, Al-Khalidi HR, Junge C, Nada A, Hunt AS, Losordo DW; RENEW Investigators.

JACC Cardiovasc Interv. 2016 Aug 8;9(15):1576-85. doi: 10.1016/j.jcin.2016.05.003.

6.

Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials.

Poulin MF, Deka A, Mohamedali B, Schaer GL.

Cell Transplant. 2016 Nov;25(11):1911-1923. doi: 10.3727/096368916X692087. Review.

PMID:
27349212
7.

Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article.

Moseley AD, Collado FM, Volgman AS, Schaer GL, Snell RJ.

Curr Atheroscler Rep. 2016 Jul;18(7):45. doi: 10.1007/s11883-016-0595-0. Review.

PMID:
27260146
8.

Comparative Analysis of Radial Versus Femoral Diagnostic Cardiac Catheterization Procedures in a Cardiology Training Program.

Singh G, Campos E, Kavinsky CJ, Snell JR, Schaer GL, Jolly N.

J Invasive Cardiol. 2016 Jun;28(6):254-7. Epub 2016 May 15.

9.

Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.

Henry TD, Schaer GL, Traverse JH, Povsic TJ, Davidson C, Lee JS, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Patel AN, Riedel N, Junge C, Hunt A, Kereiakes DJ, White C, Harrington RA, Schatz RA, Losordo DW; ACT.

Cell Transplant. 2016;25(9):1701-1711. Epub 2016 May 4.

PMID:
27151378
10.

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.

Patel AN, Henry TD, Quyyumi AA, Schaer GL, Anderson RD, Toma C, East C, Remmers AE, Goodrich J, Desai AS, Recker D, DeMaria A; ixCELL-DCM Investigators.

Lancet. 2016 Jun 11;387(10036):2412-21. doi: 10.1016/S0140-6736(16)30137-4. Epub 2016 Apr 5. Erratum in: Lancet. 2016 Jun 11;387(10036):2382.

PMID:
27059887
11.

The ixCELL-DCM Trial: Rationale and Design.

Henry TD, Schaer GL, DeMaria A, Recker D, Remmers AE, Goodrich J, Patel AN.

Cell Transplant. 2016;25(9):1689-1699. Epub 2016 Mar 22.

PMID:
27009022
12.

An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis.

Shan Z, Qin S, Li W, Wu W, Yang J, Chu M, Li X, Huo Y, Schaer GL, Wang S, Zhang C.

J Am Coll Cardiol. 2015 Jun 16;65(23):2526-37. doi: 10.1016/j.jacc.2015.03.570.

13.

Implementation of miRNAs to Reduce In-Stent Restenosis in the Future.

Schaer GL, Zhang C.

J Am Coll Cardiol. 2015 Jun 2;65(21):2328-30. doi: 10.1016/j.jacc.2015.04.008. No abstract available.

14.

Impact of a novel interventional platform and hospital design on the door-to-balloon time in patients presenting with ST-segment elevation myocardial infarction.

Poulin MF, Appis A, Purim-Shem-Tov Y, Schaer GL, Snell J.

Crit Pathw Cardiol. 2015 Mar;14(1):39-43. doi: 10.1097/HPC.0000000000000039.

PMID:
25679087
15.

Successful collaborative model for STEMI care between a STEMI-referral and a STEMI receiving center.

Purim-Shem-Tov YA, Schaer GL, Malik K, McLaughlin RR, Haw JM, Melgoza NA, Franco MM.

Crit Pathw Cardiol. 2014 Dec;13(4):131-4. doi: 10.1097/HPC.0000000000000025.

PMID:
25396288
16.

Adverse outcomes in hospitalized patients who develop ST-elevation myocardial infarction.

Richmond T, Holoshitz N, Haryani A, Purim-Shem-Tov Y, Sharma G, Schaer GL.

Crit Pathw Cardiol. 2014 Jun;13(2):62-5. doi: 10.1097/HPC.0000000000000009.

PMID:
24827882
17.

A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.

Povsic TJ, Junge C, Nada A, Schatz RA, Harrington RA, Davidson CJ, Fortuin FD, Kereiakes DJ, Mendelsohn FO, Sherman W, Schaer GL, White CJ, Stewart D, Story K, Losordo DW, Henry TD.

Am Heart J. 2013 Jun;165(6):854-861.e2. doi: 10.1016/j.ahj.2013.03.003. Epub 2013 Apr 19.

PMID:
23708155
18.

An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure.

Penn MS, Mendelsohn FO, Schaer GL, Sherman W, Farr M, Pastore J, Rouy D, Clemens R, Aras R, Losordo DW.

Circ Res. 2013 Mar 1;112(5):816-25. doi: 10.1161/CIRCRESAHA.111.300440. Epub 2013 Feb 21.

PMID:
23429605
19.

Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model.

Kumar A, Haralampus CA, Hughes M, Rouy D, Cresswell N, Braun R, Turner D, Amrani D, Motlagh D, Schaer GL.

Catheter Cardiovasc Interv. 2013 May;81(6):970-7. doi: 10.1002/ccd.24476. Epub 2012 Nov 9.

PMID:
22581763
20.

Achieving high quality in ST-segment elevation myocardial infarction care: one urban academic medical center experience.

Purim-Shem-Tov YA, Melgoza N, Haw J, Schaer GL, Calvin JE, Rumoro DP.

Crit Pathw Cardiol. 2012 Mar;11(1):32-9. doi: 10.1097/HPC.0b013e31824303f1.

PMID:
22337219

Supplemental Content

Loading ...
Support Center